<DOC>
	<DOCNO>NCT00003793</DOCNO>
	<brief_summary>RATIONALE : Determination genetic marker soft tissue sarcoma rhabdomyosarcoma may help doctor identify patient risk therapy-related leukemia . PURPOSE : Clinical trial study genetic test child soft tissue sarcoma rhabdomyosarcoma identify child risk develop leukemia chemotherapy use treat sarcoma .</brief_summary>
	<brief_title>Genetic Study Children With Soft Tissue Sarcoma Rhabdomyosarcoma</brief_title>
	<detailed_description>OBJECTIVES : - Identify genetically susceptible patient therapy-induced myelodysplastic syndrome acute myelogenous leukemia ( t-MDS/AML ) prior initiation high-dose chemotherapy sarcoma . - Identify patient increase risk t-MDS/AML therapy . OUTLINE : Blood collect patient diagnosis ( preferably chemotherapy transfusion ) , end therapy , 6 month , 1 year , 2 year , 3 year therapy . Blood specimen examine clonality analysis ( HUMARA ) , variant cell frequency ( glycophorin A assay ) , GST NAT2/CYP1A1 genotyping , microsatellite instability , ras mutation detection ( single strand conformation polymorphism sequence mutant allele ) . Patients receive result genetic test result influence type duration treatment . PROJECTED ACCRUAL : A total 321 patient accrue study within 4 year .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis sarcoma include : Rhabdomyosarcoma Ewing 's sarcoma Primitive neuroectodermal tumor Fibrosarcoma Malignant peripheral nerve sheath tumor Synovial cell sarcoma Osteosarcoma Other soft tissue sarcoma Must currently receive intensive highdose chemotherapy sarcoma PATIENT CHARACTERISTICS : Age : Children Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
	<keyword>localize osteosarcoma</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>childhood soft tissue sarcoma</keyword>
	<keyword>nonmetastatic childhood soft tissue sarcoma</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>childhood fibrosarcoma</keyword>
	<keyword>childhood synovial sarcoma</keyword>
	<keyword>childhood neurofibrosarcoma</keyword>
	<keyword>previously untreated childhood rhabdomyosarcoma</keyword>
	<keyword>localize Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
</DOC>